X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2330) 2330
mesalamine - therapeutic use (1461) 1461
male (1256) 1256
mesalamine (1242) 1242
anti-inflammatory agents, non-steroidal - therapeutic use (1180) 1180
gastroenterology & hepatology (1166) 1166
female (1157) 1157
colitis, ulcerative - drug therapy (1037) 1037
adult (968) 968
middle aged (748) 748
ulcerative colitis (700) 700
inflammatory-bowel-disease (573) 573
crohn disease - drug therapy (558) 558
treatment outcome (505) 505
aminosalicylic acids - therapeutic use (490) 490
5-aminosalicylic acid (458) 458
pharmacology & pharmacy (440) 440
aged (435) 435
inflammatory bowel disease (428) 428
mesalamine - administration & dosage (395) 395
mesalazine (379) 379
adolescent (356) 356
crohn's disease (344) 344
inflammatory bowel diseases - drug therapy (332) 332
therapy (329) 329
ulcerative-colitis (328) 328
immunosuppressive agents - therapeutic use (325) 325
anti-inflammatory agents, non-steroidal - administration & dosage (324) 324
crohns-disease (321) 321
double-blind (307) 307
mesalamine - adverse effects (305) 305
anti-inflammatory agents - therapeutic use (295) 295
recurrence (286) 286
sulfasalazine - therapeutic use (273) 273
anti-inflammatory agents, non-steroidal - adverse effects (268) 268
sulfasalazine (263) 263
administration, oral (246) 246
animals (246) 246
azathioprine - therapeutic use (234) 234
remission induction (218) 218
severity of illness index (211) 211
infliximab (205) 205
young adult (200) 200
medicine, general & internal (191) 191
remission (191) 191
adrenal cortex hormones - therapeutic use (188) 188
double-blind method (188) 188
colonoscopy (179) 179
drug therapy, combination (177) 177
time factors (176) 176
risk factors (172) 172
azathioprine (170) 170
care and treatment (168) 168
colitis, ulcerative - pathology (167) 167
colitis, ulcerative - complications (166) 166
gastroenterology (166) 166
gastrointestinal agents - therapeutic use (164) 164
inflammatory bowel diseases (164) 164
child (158) 158
follow-up studies (156) 156
colon (151) 151
surgery (150) 150
aminosalicylic acids - administration & dosage (149) 149
colitis, ulcerative - diagnosis (146) 146
management (145) 145
retrospective studies (145) 145
aminosalicylic acids - adverse effects (143) 143
colitis (142) 142
crohn disease - surgery (139) 139
mesalamine - pharmacology (137) 137
medicine & public health (136) 136
antibodies, monoclonal - therapeutic use (134) 134
maintenance (131) 131
colitis, ulcerative - therapy (130) 130
prevention (129) 129
randomized controlled trials as topic (129) 129
rats (129) 129
prospective studies (127) 127
drug therapy (126) 126
gastroenterology and hepatology (124) 124
dose-response relationship, drug (123) 123
analysis (122) 122
inflammatory bowel-disease (120) 120
glucocorticoids - therapeutic use (119) 119
enema (116) 116
colitis - drug therapy (115) 115
mercaptopurine - therapeutic use (115) 115
aged, 80 and over (114) 114
secondary prevention (113) 113
inflammation (112) 112
crohn disease - complications (109) 109
crohn disease - diagnosis (109) 109
prognosis (109) 109
abridged index medicus (108) 108
5-asa (107) 107
disease (106) 106
efficacy (106) 106
clinical trials as topic (105) 105
colon - pathology (103) 103
drug administration schedule (103) 103
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2424) 2424
German (99) 99
Spanish (40) 40
French (39) 39
Japanese (34) 34
Korean (27) 27
Russian (16) 16
Italian (11) 11
Danish (10) 10
Dutch (9) 9
Hungarian (9) 9
Portuguese (8) 8
Chinese (7) 7
Finnish (7) 7
Hebrew (3) 3
Norwegian (3) 3
Polish (3) 3
Czech (1) 1
Serbian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2017, Volume 2017, Issue 11, p. CD006096
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2016, Volume 2016, Issue 7, p. CD008870
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2020, Issue 3, p. CD000545
Background The results from controlled clinical trials investigating the efficacy of azathioprine and 6‐mercaptopurine for the treatment of active Crohn's... 
Mesalamine | Immunosuppressive Agents | Glucocorticoids | Gastroenterology & hepatology | Azathioprine or 6‐mercaptopurine therapy | Crohn Disease | Induction Chemotherapy | Prednisone | Withholding Treatment | Antimetabolites | Randomized Controlled Trials as Topic | Crohn's disease: induction of remission | Inflammatory bowel disease | CROHN'S DISEASE ‐ INDUCTION OF REMISSION | Infliximab | Sulfasalazine | Azathioprine | Medicine General & Introductory Medical Sciences | Mercaptopurine | LONG-TERM | CLINICAL-PHARMACOLOGY | Induction Chemotherapy [methods] | Humans | 6-Mercaptopurine [adverse effects; therapeutic use] | RANDOMIZED-TRIAL | EARLY COMBINED IMMUNOSUPPRESSION | Immunosuppressive Agents [adverse effects; therapeutic use] | INFLIXIMAB PLUS AZATHIOPRINE | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | THERAPY | Crohn Disease [drug therapy] | DOUBLE-BLIND TRIAL | TERM-FOLLOW-UP | Azathioprine [adverse effects; therapeutic use] | MYCOPHENOLATE-MOFETIL | Sulfasalazine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - administration & dosage | Prednisone - administration & dosage | Immunosuppressive Agents - therapeutic use | Induction Chemotherapy - methods | Mercaptopurine - adverse effects | Antimetabolites - therapeutic use | Infliximab - therapeutic use | Antimetabolites - adverse effects | Mercaptopurine - therapeutic use | Crohn Disease - drug therapy | Mesalamine - therapeutic use | Adult | Immunosuppressive Agents - adverse effects | Induction Chemotherapy - statistics & numerical data | Azathioprine - adverse effects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 11/2017, Volume 2017, Issue 11, p. CD003575
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 5, p. CD000478
Background Maintenance of remission is a major issue in inflammatory bowel disease. In ulcerative colitis, the evidence for the effectiveness of azathioprine... 
Colitis, Ulcerative | Mesalamine | Gastroenterology & hepatology | Anti‐Inflammatory Agents, Non‐Steroidal | Secondary Prevention | Antimetabolites | Randomized Controlled Trials as Topic | Inflammatory bowel disease | Ulcerative colitis: maintenance of remission | Sulfasalazine | Maintenance Chemotherapy | Azathioprine and 6‐mercaptopurine therapy | Azathioprine | Medicine General & Introductory Medical Sciences | ULCERATIVE COLITIS ‐ MAINTENANCE OF REMISSION | Mercaptopurine | MANAGEMENT | METHYLTRANSFERASE | QUALITY | EFFICACY | STEROID-RESISTANT | Humans | 6-Mercaptopurine [adverse effects; therapeutic use] | INTRAVENOUS CYCLOSPORINE | METHOTREXATE | RANDOMIZED CONTROLLED-TRIAL | TERM | Mesalamine [therapeutic use] | Anti-Inflammatory Agents, Non-Steroidal [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | Maintenance Chemotherapy [methods] | Sulfasalazine [therapeutic use] | Colitis, Ulcerative [drug therapy] | Antimetabolites [adverse effects; therapeutic use] | Azathioprine [adverse effects; therapeutic use] | Sulfasalazine - therapeutic use | Azathioprine - therapeutic use | Mercaptopurine - adverse effects | Antimetabolites - therapeutic use | Antimetabolites - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Maintenance Chemotherapy - methods | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Mercaptopurine - therapeutic use | Mesalamine - therapeutic use | Adult | Colitis, Ulcerative - drug therapy | Azathioprine - adverse effects
Journal Article
Journal Article
Journal Article